Literature DB >> 2913026

Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 and comparison of the test with enzyme-linked immunosorbent assay and Western blot (immunoblot) analysis.

M B Vasudevachari1, K W Uffelman, T C Mast, R L Dewar, V Natarajan, H C Lane, N P Salzman.   

Abstract

A passive hemagglutination test (PHA) was developed for detecting antibodies to human immunodeficiency virus type 1 (HIV-1) utilizing sheep erythrocytes cross-linked with purified envelope glycoprotein (gp160) of HIV-1. In an analysis of 216 human serum samples, 100% correlation was observed in 86 reactive and 124 nonreactive serum samples between PHA and commercial enzyme-linked immunosorbent assays and Western blot (immunoblot) analysis. Serum samples from gp160-immunized chimpanzees also reacted equally well in PHA. The test is simple, rapid, and inexpensive, thus providing an alternate, quick method of detecting HIV antibodies. These advantages and the thermal stability of the reagents that are used make this an attractive alternative for detecting prior exposure of individuals to HIV-1.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2913026      PMCID： PMC267257          DOI： 10.1128/jcm.27.1.179-181.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  24 in total

1.  False-negative ELISA result for HIV antibody due to an apparent prozone phenomenon.

Authors:  A Imrie; S Best; R Penny; D A Cooper
Journal:  Med J Aust       Date:  1987-07-06       Impact factor: 7.738

2.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Authors:  M G Sarngadharan; M Popovic; L Bruch; J Schüpbach; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

3.  Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome.

Authors:  P M Feorino; V S Kalyanaraman; H W Haverkos; C D Cabradilla; D T Warfield; H W Jaffe; A K Harrison; M S Gottlieb; D Goldfinger; J C Chermann
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

4.  Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody.

Authors:  R M Thorn; G A Beltz; C H Hung; B F Fallis; S Winkle; K L Cheng; D J Marciani
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

5.  Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs.

Authors:  L W Kitchen; F Barin; J L Sullivan; M F McLane; D B Brettler; P H Levine; M Essex
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

6.  A new agglutination test for serum antibodies to adult T-cell leukemia virus.

Authors:  M Ikeda; R Fujino; T Matsui; T Yoshida; H Komoda; J Imai
Journal:  Gan       Date:  1984-10

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.

Authors:  V S Kalyanaraman; C D Cabradilla; J P Getchell; R Narayanan; E H Braff; J C Chermann; F Barré-Sinoussi; L Montagnier; T J Spira; J Kaplan
Journal:  Science       Date:  1984-07-20       Impact factor: 47.728

9.  Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.

Authors:  J Schüpbach; M Popovic; R V Gilden; M A Gonda; M G Sarngadharan; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728
View more
  5 in total

1.  Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis.

Authors:  E O Hochleitner; C Borchers; C Parker; R J Bienstock; K B Tomer
Journal:  Protein Sci       Date:  2000-03       Impact factor: 6.725

2.  Detection of antibodies to human immunodeficiency virus type 1 in whole blood and saliva by using a passive hemagglutination test.

Authors:  M B Vasudevachari; K Uffelman; P F Pierce; H C Lane; N P Salzman
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

3.  Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 in developing countries.

Authors:  S C Arya; V P Pathak; S J Ashraf; S K Ashraf
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

4.  Whole-blood agglutination assay for on-site detection of human immunodeficiency virus infection.

Authors:  Amita Gupta; Vijay K Chaudhary
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 5.  The diagnosis of human immunodeficiency virus infection: progress in less than five years.

Authors:  F J Michalski
Journal:  Yale J Biol Med       Date:  1989 Mar-Apr
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.